Home › Funds › OLD MISSION CAPITAL LLC › GSK

OLD MISSION CAPITAL LLC position in GSK

GSK PLC · Health Care

OLD MISSION CAPITAL LLC reported holding 455,346 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$23.9M, representing 0.86% of its reported portfolio and ranking #15 among its reported holdings. OLD MISSION CAPITAL LLC has disclosed GSK holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)455.35K sh
Reported value held$23.87M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How OLD MISSION CAPITAL LLC's GSK position evolved

OLD MISSION CAPITAL LLC first disclosed a stake in GSK in Q3 2023 at 76,837 shares (US$2.8M). The position peaked in Q1 2026 at 435,091 shares, worth US$24.0M. Across 8 filings, OLD MISSION CAPITAL LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 455,346 shares valued at US$23.9M — an increase of 20,255 shares quarter over quarter.. Notable position changes include a 160% increase in Q4 2023 (shares rose 16% over the following quarter), a 41% increase in Q2 2024 (shares rose 6% over the following quarter), a 172% increase in Q1 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 76.84K $2.79M New
Q4 2023 199.63K $7.40M Add
Q1 2024 277.62K $11.90M Add
Q2 2024 392.41K $15.11M Add
Q3 2024 332.09K $13.58M Reduce
Q4 2025 159.91K $7.84M New
Q1 2026 435.09K $24.01M Add
Q2 2026 455.35K $23.87M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has OLD MISSION CAPITAL LLC held GSK?

OLD MISSION CAPITAL LLC has disclosed GSK holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is OLD MISSION CAPITAL LLC's current position in GSK?

As of Q2 2026, OLD MISSION CAPITAL LLC holds 455.35K shares of GSK (GSK PLC), valued at $23.87M, representing 0.86% of its reported portfolio and ranking #15.

Has OLD MISSION CAPITAL LLC been buying or selling GSK?

In the latest 13F filing (Q2 2026), OLD MISSION CAPITAL LLC increased its position in GSK. The position peaked in Q1 2026 at 435.09K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.